125 related articles for article (PubMed ID: 29730435)
1. Esophageal Neuroendocrine Carcinoma Presented as a Flat Depressed Lesion.
Abe K; Yanagisawa D; Numakura S
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):A31-A32. PubMed ID: 29730435
[No Abstract] [Full Text] [Related]
2. [Primary superficial small cell neuroendocrine carcinoma of esophagus: clinicopathologic and immunohistochemical analysis of 15 cases].
Lu J; Lü N; Xue LY; Zou SM; Liu XY; Wen P
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):736-40. PubMed ID: 22336155
[TBL] [Abstract][Full Text] [Related]
3. Large-cell Neuroendocrine Carcinoma of the Endometrium in Myomatous Uterus.
Shopov ST; Anavi BL; Krastev DK
Folia Med (Plovdiv); 2020 Jun; 62(2):412-417. PubMed ID: 32666759
[TBL] [Abstract][Full Text] [Related]
4. A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: Evaluation of 24 cases.
Leblebici C; Yeni B; Savli TC; Aydın Ö; Güneş P; Cinel L; Şimşek BÇ; Yıldız P; Tuncel D; Kayahan S
Ann Diagn Pathol; 2019 Jun; 40():53-58. PubMed ID: 31031215
[TBL] [Abstract][Full Text] [Related]
5. Syntaxin 1: A Novel Robust Immunophenotypic Marker of Neuroendocrine Tumors.
Kővári B; Turkevi-Nagy S; Báthori Á; Fekete Z; Krenács L
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059362
[TBL] [Abstract][Full Text] [Related]
6. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
[TBL] [Abstract][Full Text] [Related]
7. An esophageal collision tumor.
Adachi K; Tateno Y; Okada H
Clin Gastroenterol Hepatol; 2014 Mar; 12(3):e17-8. PubMed ID: 23962544
[No Abstract] [Full Text] [Related]
8. Double neuroendocrine ductal carcinomas in situ coexisting with a background of diffuse idiopathic neuroendocrine cell hyperplasia of breast: a case report and hypothesis of neuroendocrine tumor development.
Miura K; Nasu H; Ogura H
Pathol Int; 2012 May; 62(5):331-4. PubMed ID: 22524661
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
[No Abstract] [Full Text] [Related]
10. CD56 expression in basaloid anal squamous cell carcinoma - A potential diagnostic pitfall.
Madahian S; Judelson R; Zhu X; Meng X; Dresser K; Hutchinson L; Bledsoe JR
Ann Diagn Pathol; 2021 Aug; 53():151758. PubMed ID: 33989959
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing neuroendocrine carcinomas of the lung: A clinicopathologic and immunohistochemical study of 10 cases.
Kalhor N; Suster S; Moran CA
Am J Clin Pathol; 2010 Apr; 133(4):618-22. PubMed ID: 20231615
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma.
Murakami K; Kumata H; Miyagi S; Kamei T; Sasano H
Pathol Int; 2021 Oct; 71(10):682-691. PubMed ID: 34320691
[TBL] [Abstract][Full Text] [Related]
13. [Expression of CD56, as a potential diagnostic marker, in small cell carcinoma].
Yun JP; Xiang J; Hou JH; Tian QH; Fu J
Ai Zheng; 2005 Sep; 24(9):1140-3. PubMed ID: 16159442
[TBL] [Abstract][Full Text] [Related]
14. Distribution of Neuroendocrine Marker-Positive Cells in Colorectal Cancer Tissue and Normal Mucosal Tissue: Consideration of Histogenesis of Neuroendocrine Cancer.
Ogimi T; Sadahiro S; Kamei Y; Chan LF; Miyakita H; Saito G; Okada K; Suzuki T; Kajiwara H
Oncology; 2019; 97(5):294-300. PubMed ID: 31390635
[TBL] [Abstract][Full Text] [Related]
15. Ovarian neuroendocrine carcinoma of metastatic origin: clues for diagnosis.
Karpathiou G; Matias-Guiu X; Mobarki M; Vermesch C; Stachowicz ML; Chauleur C; Peoc'h M
Hum Pathol; 2019 Mar; 85():309-312. PubMed ID: 30171991
[TBL] [Abstract][Full Text] [Related]
16. A resected case of neuroendocrine carcinoma of the stomach with unusual lymph node metastasis.
Taguchi J; Shinozaki K; Baba S; Kurogi J; Nakane T; Kinoshita Y; Ishii K; Ueno T; Torimura T; Yano H
Med Mol Morphol; 2016 Mar; 49(1):34-41. PubMed ID: 25827661
[TBL] [Abstract][Full Text] [Related]
17. Postradiotherapy small cell neuroendocrine carcinoma of base of tongue: An unusual clinical and site presentation.
Jha V; Sharma P; Yadav AK; Mandal AK
J Postgrad Med; 2017; 63(1):50-52. PubMed ID: 27853043
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of FIGO stage I-IIA small-cell neuroendocrine carcinoma of the uterine cervix.
Ning L; Zhang W; Yang J; Cao D; Lang J; Yu M
Int J Gynaecol Obstet; 2018 Sep; 142(3):374-375. PubMed ID: 29858870
[No Abstract] [Full Text] [Related]
19. [Clear cell renal cell carcinoma with neuroendocrine differentiation and liver metastasis: report of a case].
Yang L; Mu D; Yuan Y; Zhang D; Sun J; Cai S; Gao Y
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):278-9. PubMed ID: 24915823
[No Abstract] [Full Text] [Related]
20. A case of cytokeratin 20-positive large-cell neuroendocrine carcinoma of the breast.
Okoshi K; Saiga T; Hisamori S; Iwaisako K; Kobayashi H; Ogawa H
Breast Cancer; 2012 Oct; 19(4):360-4. PubMed ID: 19669861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
